KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Long-Term Deferred Tax (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Long-Term Deferred Tax for 17 consecutive years, with $5.0 billion as the latest value for Q3 2025.

  • On a quarterly basis, Long-Term Deferred Tax rose 37.46% to $5.0 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $5.0 billion, a 37.46% increase, with the full-year FY2024 number at $4.2 billion, up 53.03% from a year prior.
  • Long-Term Deferred Tax was $5.0 billion for Q3 2025 at Bristol Myers Squibb, up from $4.6 billion in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $5.0 billion in Q3 2025 to a low of $650.0 million in Q2 2021.
  • A 5-year average of $2.3 billion and a median of $1.5 billion in 2023 define the central range for Long-Term Deferred Tax.
  • Peak YoY movement for Long-Term Deferred Tax: tumbled 40.26% in 2021, then surged 138.38% in 2024.
  • Bristol Myers Squibb's Long-Term Deferred Tax stood at $1.4 billion in 2021, then fell by 6.6% to $1.3 billion in 2022, then soared by 105.95% to $2.8 billion in 2023, then soared by 53.03% to $4.2 billion in 2024, then grew by 17.12% to $5.0 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Long-Term Deferred Tax are $5.0 billion (Q3 2025), $4.6 billion (Q2 2025), and $4.0 billion (Q1 2025).